KYNB
KYNB
NASDAQ · Biotechnology

Kyntra Bio Inc

$3.45
-0.14 (-3.90%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 8 80%
Hold 2 20%
Sell 0 0%
Price Target
Analyst Price Target +824.9% upside
Low Target $24.67
Average Target $31.91
High Target $44.05
Current Price $3.45
Current
$3.45
Target
$31.91
$24.67 $31.91 avg $44.05
Scenario Analysis
Bear Case
$24.67
615.1%
Low target
Base Case
$31.91
+824.9%
Avg target
Bull Case
$44.05
+1,176.8%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$11.39
-69.7% from high
52-Week Low
$3.60
+-4.2% from low
Target vs 52W High
$31.91
+180.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%